Additionally, miR-182 plays an important role in drug resistance and upregulated miR-182-induced cisplatin resistance in HCC cells by regulating tumor protein 53-induced nuclearprotein 1 (TP53INP1) [23]. This evidence concerns the gene TP53INP1 and hepatocellular carcinoma.